Alvotech Biopharmaceuticals (ALVO): Narxning prognoz qilingan daromadga nisbati
Joriy forward P/S koeffitsiyenti Alvotech kompaniyasiga nisbatan bozor kutganlarini aks ettiradi, uning muvaffaqiyati tartibga soluvchi organlarning tasdiqlari va patent urushlarining natijasiga bog'liq. 3.70 yakuniy daraja belgisi vazifasini o'taydi. Biznes qat'iy FDA nazorati va sezilarli lobbi faoliyati bilan yuzlashmoqda. Shu bilan birga, yuqori texnologiyali zavod maksimal samaradorlikda ishlamoqda va uskunalar to'xtovsiz ravishda ishlab chiqarish quvvatlarini muntazam ravishda kengaytirmoqda.
Alvotech Biopharmaceuticals (ALVO) kompaniyasining tahliliy kesimlari
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- birja kapitallashuvi ma'lumotlari:
- xususiy kapitalning balans qiymati ko'rsatkichlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Umumiy qarzning xususiy kapitalga nisbati Alvotech|ALVO - Uzoq muddatli kreditlarning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Alvotech|ALVO - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Alvotech Biopharmaceuticals|ALVO - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli qarzlari Alvotech|Tezkor likvidlik koeffitsiyenti alvotech.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ALVO - Sof foyda|Kutilayotgan foyda Alvotech|ALVO - Narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Alvotech Corp|ALVO - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Alvotech Biopharmaceuticals|ALVO - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Alvotech|ALVO - So'nggi 12 oy davomida bitta aksiya uchun foyda|Choraklik EPS foyda o'sishi alvotech.com|ALVO - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Alvotech
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
Kompaniyaning dastlabki tahlili:Alvotech SA ALVO
Forward P/S koeffitsiyenti biznesning bozor qiymatini kutilayotgan daromadga nisbatan belgilaydi va choraklik hisobotlarni kutmasdan kapitalizatsiyani real vaqt rejimida baholash imkonini beradi. Forward P/S koeffitsiyentini tahlil qilish orqali investor Alvotech (ALVO) rahbariyatining biosimilarlarni kengaytirish va monopoliyani buzish borasidagi ambitsiyalari narxda qanday aks etganini ko'rishi mumkin, bu esa ishlab chiqarishni kengaytirish davrida kirish nuqtasini aniqlashga yordam beradi.
Alvotech (ALVO) raqobatchilari
Forvard P/S multiplikatori HLN (Haleon)|Forvard P/S multiplikatori Kenvue Inc KVUE|VRNA - Narxning prognoz qilingan daromadga nisbati|MENS: Narxning prognoz qilingan daromadga nisbati|LGND (Ligand Pharmaceuticals) - Forvard narx/daromad multiplikatori|AMRX (amneal.com) - Narxning prognoz qilingan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Perrigo|Bozor kapitallashuvining kelajakdagi daromadga nisbati Liquidia Corp LQDA|Forvard narx/daromad multiplikatori GLPG (Galapagos Genomics)|Narxning kutilayotgan daromadga nisbati ANIP|Forvard P/S multiplikatori MNKD (MannKind Corporation)|amphastar.com (AMPH) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|Pacira BioSciences, Inc. - Forvard P/S multiplikatori|ARS Pharmaceuticals Inc (SPRY) - Forvard narx/daromad multiplikatori|TBPH: Forvard P/S multiplikatori|Aquestive Corp - Sotuvga nisbatan forvard narx|SCPH (scPharmaceuticals, Inc.) - Forvard P/S multiplikatori|Forvard P/S multiplikatori Tectonic|Narxning prognoz qilingan daromadga nisbati Tonix Pharmaceuticals Holding Corp. (TNXP)|Narxning prognoz qilingan daromadga nisbati SXTC (sxtchina.com)|Eupraxia Pharmaceuticals Inc. - Forvard narx/daromad multiplikatori|BioHarvest Sciences Inc - Narxning prognoz qilingan daromadga nisbati|EXOZ - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati Oramed Pharmaceuticals|enterabio.com (ENTX) - Narxning prognoz qilingan daromadga nisbati|Kelajakdagi narxning daromadga nisbati HYFT (MindWalk Holdings, Inc.)|ABVC (ABVC BioPharma Inc) - Forvard P/S multiplikatori|CPIX: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori QNTM|Forvard P/S multiplikatori fibrogen.com (FGEN)|Narxning prognoz qilingan daromadga nisbati Telomir Pharmaceuticals, Inc. TELO|Sotuvga nisbatan forvard narx RANI|SNYR - Narxning prognoz qilingan daromadga nisbati|Rallybio Corporation (RLYB) - Forvard narx/daromad multiplikatori|LEXX: Forvard P/S multiplikatori|pulmatrix.com (PULM) - Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori PTHL|APM: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics, Inc (LYRA)|IBO - Bozor kapitallashuvining kelajakdagi daromadga nisbati|TNF Pharmaceuticals, Inc. - Forvard narx/daromad multiplikatori|Narxning kutilayotgan daromadga nisbati YCBD (cbdMD Inc.)|PainReform - Forvard P/S multiplikatori|Sotuvga nisbatan forvard narx CYTO (Altamira Therapeutics)|LIPO: Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati OptiNose Corp (OPTN)|Narxning prognoz qilingan daromadga nisbati Pieris Pharmaceuticals|PROC: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori PTPI|Forvard P/S multiplikatori Qilian International Holding Group (QLI)|Narxning prognoz qilingan daromadga nisbati ACELYRIN, Inc. SLRN|TFF Pharmaceuticals, Inc - Narxning prognoz qilingan daromadga nisbati
